NR4A1 impacts both fatty acid synthesis and oxidation, providing a dual advantage of metabolic disruption and reduced tumor growth, presenting a promising strategy for cancers heavily reliant on lipid metabolism, such as breast cancer. Here, NR4A1 is linked to breast carcinoma.